FindTrial
Sign In

Effect of montmorillonite powder retention enema on intestinal mucosal barrier function in patients with acute pancreatitis: a prospective randomized controlled trial

Effect of montmorillonite powder retention enema on intestinal mucosal barrier function in patients with acute pancreatitis: a prospective randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16010236
Enrollment
Unknown
Registered
2016-12-23
Start date
2017-02-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute pancreatitis

Interventions

Control group:Conventional treatment
Observation group:Montmorillonite scattered enema

Sponsors

Chengdu First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Onset within 72 hours of acute pancreatitis patients

Exclusion criteria

Exclusion criteria: Age 75 years, pregnant women, hemorrhoids and other diseases should not be enema, refused to cooperate with enema

Design outcomes

Primary

MeasureTime frame
Blood inflammatory factor(WBC, CRP, IL-6);Blood D-lactic acid, endotoxin and DAO;Length of hospitalization;—

Countries

China

Contacts

Public ContactZhao Xianlin

Chengdu First People's Hospital

343219097@qq.com+86 13548158828

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026